FDA Inspection
UF Health Shands Medical Laboratories Blood BankUF Health Shands Medical Laboratories Blood Bank – FDA Inspection, Feb 25, 2016
Record Details
This FDA Inspection record concerns UF Health Shands Medical Laboratories Blood Bank, with an inspection on February 25, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 25, 2016
- Product Type
- Biologics
View Company Profile
ID · a5b17c2c-0cd6-4be6-bae2-fcc13d4ef02e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 967913
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of UF Health Shands Medical Laboratories Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2025 | Not classified | Florida District Office | |
| April 5, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 25, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 23, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for UF Health Shands Medical Laboratories Blood Bank
- FDA Inspection 1280793 - 2025-08-18
- FDA Inspection 1202804 - 2023-04-05
- FDA Inspection 1039044 - 2018-01-25
- FDA Inspection 888207 - 2014-07-23
- FDA Inspection 798187 - 2012-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.